SciELO - Scientific Electronic Library Online

 
vol.24 número9Utilización de estudios de diagnóstico radiológico en una unidad de especialidades médicasSarcoidosis y carcinoma fibrolamelar del hígado índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Anales de Medicina Interna

versão impressa ISSN 0212-7199

Resumo

CAMPOS, A.; GUARDIA, F. de la; REYES, J.  e  FERRERO, C.. Adverse reactions induced by gadopentatate dimeglumine in magnetic resonance imaging. An. Med. Interna (Madrid) [online]. 2007, vol.24, n.9, pp.428-430. ISSN 0212-7199.

Background and objectives: It is considered that the Gadolinium salts used as a contrast medium in the Magnetic Resonance Imaging (MRI) studies present an index of adverse reactions below the iodine contrast mediums. The main objective of this study is to determine, in our medium, the frequency and intensity of the adverse reactions related to the administration of Gadopentotate Dimeglumine (Gd-DTPA) and compare it with the rate of adverse reactions induced by the iodine contrast mediums. Material and methods: During the period comprised between 1st of January 2005 and 30th of June 2006, the adverse affects were collected for all the studies by means of MRI in which the Gd-DTPA contrast was applied, programmed or urgent, performed in Eresa Diagnosis Centres by Image located ( 11 centre in total) in the provinces of Castellón and Valencia. The adverse effects induced by the iodine salts were also collected in this period. Results: A total of 54,909 studies with magnetic resonance were performed in the refered study centres, and 12,791 studies with MCI. The total of adverse reactions observed was 62 (0.11%) and 47 (0.36%) respectively. The profile of adverse reactions with both contrast mediums was similar, except in the moderate reactions where we objectively observed a greater percentage of palpebral edema and dyspnea with the usage of MCI than with Gd-DTPA. No cases of anaphylaxia or exitus were observed. Conclusions: The data contributed by this series support a safety profile of Gadolinium superior to that of the MCI in line with the results shown by extensive published series.

Palavras-chave : Adverse reaction; Allergy; Contrast media; Gadolinium; Iodine; Magnetic resonance imaging.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons